$DRIO DarioHealth® Clinical Study Data Shows the
Post# of 42117
Dario Membership users with diabetes achieved a 39% increase of in-range, blood-glucose measurements
45% of the study group reduced their average blood-glucose levels to under 140 mg/dL, in line with a pre-diabetes level
NEW YORK and CAESAREA, Israel, Aug. 12, 2019 /PRNewswire/ -- DarioHealth Corp. (DRIO) ("DarioHealth" or "Dario" , a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators ("AADE" conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario's digital therapeutics platform and dedicated one-on-one personal health coaching.
https://finance.yahoo.com/news/dariohealth-cl...00870.html